The prevalence and clinical features of fibromyalgia in Chinese hospital patients with primary headache: The survey of fibromyalgia comorbid with headache

The aims were to explore the prevalence and clinical features of fibromyalgia in Chinese hospital patients with primary headache.

[1]  J. Jiao,et al.  Demographic Characteristics and Clinical Features of Fibromyalgia in China: A Cross-Sectional Study , 2021, Rheumatology and Therapy.

[2]  S. Cuzzocrea,et al.  Fibromyalgia: Pathogenesis, Mechanisms, Diagnosis and Treatment Options Update , 2021, International journal of molecular sciences.

[3]  Xiaohua Chen,et al.  Association Between Preadmission Metformin Use and Outcomes in Intensive Care Unit Patients With Sepsis and Type 2 Diabetes: A Cohort Study , 2021, Frontiers in Medicine.

[4]  M. Underwood,et al.  Pregabalin and gabapentin for pain , 2020, BMJ.

[5]  J. Salas,et al.  Gender-Stratified Prevalence of Psychiatric and Pain Diagnoses in a Primary Care Patient Sample with Fibromyalgia. , 2019, Pain medicine.

[6]  H. Onder,et al.  Comorbid fibromyalgia in migraine patients: clinical significance and impact on daily life , 2019, Neurological research.

[7]  T. Chuang,et al.  Bidirectional association between migraine and fibromyalgia: retrospective cohort analyses of two populations , 2019, BMJ Open.

[8]  T. Sprenger,et al.  Current Prophylactic Medications for Migraine and Their Potential Mechanisms of Action , 2018, Neurotherapeutics.

[9]  E. Loder,et al.  The Prevalence and Impact of Migraine and Severe Headache in the United States: Figures and Trends From Government Health Studies , 2018, Headache.

[10]  M. Chu,et al.  Fibromyalgia Among Patients With Chronic Migraine and Chronic Tension‐Type Headache: A Multicenter Prospective Cross‐Sectional Study – A Response , 2018, Headache.

[11]  G. Cerdá-Olmedo,et al.  Fibromyalgia: Prevalence, epidemiologic profiles and economic costs. , 2017, Medicina clinica.

[12]  M. Chu,et al.  Fibromyalgia Among Patients With Chronic Migraine and Chronic Tension‐Type Headache: A Multicenter Prospective Cross‐Sectional Study , 2017, Headache.

[13]  K Longley,et al.  EULAR revised recommendations for the management of fibromyalgia , 2016, Annals of the rheumatic diseases.

[14]  F. Cipollone,et al.  Impact of migraine on fibromyalgia symptoms , 2016, The Journal of Headache and Pain.

[15]  A. Chopra,et al.  Changes in the Prevalence of Rheumatic Diseases in Shantou, China, in the Past Three Decades: A COPCORD Study , 2015, PloS one.

[16]  F. Wolfe,et al.  The Prevalence and Characteristics of Fibromyalgia in the 2012 National Health Interview Survey , 2015, PloS one.

[17]  A. Vincent,et al.  Frequency of Migraine Headaches in Patients With Fibromyalgia , 2015, Headache.

[18]  Shengyuan Yu,et al.  The prevalence of primary headache disorders and their associated factors among nursing staff in North China , 2015, The Journal of Headache and Pain.

[19]  Shengyuan Yu,et al.  Headache Care in China , 2014, Headache.

[20]  L. Queiroz.  Worldwide Epidemiology of Fibromyalgia , 2013, Current Pain and Headache Reports.

[21]  T. Steiner,et al.  Health-care utilization for primary headache disorders in China: a population-based door-to-door survey , 2013, The Journal of Headache and Pain.

[22]  F. Wolfe,et al.  Fibromyalgia Prevalence, Somatic Symptom Reporting, and the Dimensionality of Polysymptomatic Distress: Results From a Survey of the General Population , 2013, Arthritis care & research.

[23]  T. Steiner,et al.  The Prevalence and Burden of Primary Headaches in China: A Population‐Based Door‐to‐Door Survey , 2012, Headache.

[24]  H. Diener,et al.  Prevalence of primary headaches in Germany: results of the German Headache Consortium Study , 2012, The Journal of Headache and Pain.

[25]  M. de Tommaso,et al.  Prevalence , clinical features and potential therapies for fibromyalgia in primary headaches , 2010 .

[26]  L. Minerba,et al.  [Quality of life and associated clinical distress in fibromyalgia]. , 2011, Reumatismo.

[27]  M. de Tommaso,et al.  Clinical features of headache patients with fibromyalgia comorbidity , 2011, The Journal of Headache and Pain.

[28]  F. Wolfe,et al.  Fibromyalgia Criteria and Severity Scales for Clinical and Epidemiological Studies: A Modification of the ACR Preliminary Diagnostic Criteria for Fibromyalgia , 2011, The Journal of Rheumatology.

[29]  C. Morin,et al.  The Insomnia Severity Index: psychometric indicators to detect insomnia cases and evaluate treatment response. , 2011, Sleep.

[30]  M. de Tommaso,et al.  Fibromyalgia Comorbidity in Primary Headaches , 2009, Cephalalgia : an international journal of headache.

[31]  P. Gillman.  Tricyclic antidepressant pharmacology and therapeutic drug interactions updated , 2007, British journal of pharmacology.

[32]  T. Rudy,et al.  Fibromyalgia and headache: an epidemiological study supporting migraine as part of the fibromyalgia syndrome , 2005, Clinical Rheumatology.

[33]  C. Morin,et al.  Validation of the Insomnia Severity Index as an outcome measure for insomnia research. , 2001, Sleep medicine.

[34]  J. Fuh,et al.  Use of the hospital anxiety and depression scale as a screening tool for patients with headache. , 1999, Zhonghua yi xue za zhi = Chinese medical journal; Free China ed.

[35]  R. Snaith,et al.  The Hospital Anxiety And Depression Scale , 2003, Health and quality of life outcomes.

[36]  M. Wood,et al.  Analysis and interpretation of data. , 1978, The Journal of family practice.

[37]  M. Arnold.  Headache Classification Committee of the International Headache Society (IHS) The International Classification of Headache Disorders, 3rd edition , 2018, Cephalalgia : an international journal of headache.

[38]  Heshu Sulaiman Rahman,et al.  DRAFTING A MANUSCRIPT , 2017 .

[39]  C. A. Fleming,et al.  The Acquisition of Data , 1969 .